My guess is that a few who had planned on not holding long term would have made their sales today as 2025 tax loss selling season comes to an end. Tomorrow is the last day to successfully sell and write off any loss against 24/25 FY gains. And most IRX holders are all still sitting on a paper loss.
I expect they will suffer significant seller's remorse as 25/26 FY begins. With so much news-flow around the clinical trial programs, I expect the share price will run on from here. Still think 10cents will be a distant memory once we begin our Phase 2 trial. Q3 starts in just a few days so as @MoonBuggy suggests, the Phase 2 trial really could start enrolling patients any day now!
Its exciting times!
GLTAH
Add to My Watchlist
What is My Watchlist?
